Please login (Members) to view content or
(Nonmembers) this article.
No votes yet
Genetics & Genomics

Genetic Variants Influencing Patient Response to Opioid Therapy

Marsha Tadje
ONF 2015, 42(4), 420-422 DOI: 10.1188/15.ONF.420-422

Almost every nurse can relate to examples in which an individual receiving a high dose of an opioid had no analgesic effect, whereas another experienced respiratory compromise with a small dose. In many cases, variant responses can be attributed to genetic influences responsible for metabolism of the opioid through the cytochrome p450 system (CYP), including CYP2D6, CYP3A, and CYP2B6. Variants of the mu receptor can also affect the affinity of the opioid for its receptor. A discussion of some common alleles (polymorphisms) associated with variable response to opioids is included in this article.

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or